We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Study Shows How Genome Reference Bias Can Mislead Preventive Testing

By LabMedica International staff writers
Posted on 13 Oct 2026

Whole-genome sequencing is expected to play a growing role in preventive and predictive medicine, but accurate interpretation remains a major diagnostic challenge. The approach requires comparing billions of DNA letters against a reference sequence to identify variants that may indicate disease susceptibility. When that reference does not adequately represent human genetic diversity, automated analysis can generate misleading findings. Addressing this limitation, new findings demonstrate how reference bias may affect preventive genomics and point to graph-based pangenomics as a potential solution.

Semmelweis University (Budapest, Hungary) researchers evaluated the limitations of GRCh38, the widely used international reference sequence for the human genome. Whole-genome sequencing reads the nearly complete genetic “text” of a person, including more than six billion DNA letters, about 40,000 genes, and regions that regulate gene function. In current workflows, automated software compares a person’s genome with the reference to flag variants that may be medically relevant.


Image: Image: Graphical Abstract (Nagy, G.R., Munkácsy, G., Murmu, A. et al. Beyond the linear genome: how reference bias threatens preventive medicine and geroscience. GeroScience, 2026. https://doi.org/10.1007/s11357-026-02436-z)
Image: Image: Graphical Abstract (Nagy, G.R., Munkácsy, G., Murmu, A. et al. Beyond the linear genome: how reference bias threatens preventive medicine and geroscience. GeroScience, 2026. https://doi.org/10.1007/s11357-026-02436-z)

The study, published in GeroScience, compared the whole genomes of 20 healthy Hungarians with GRCh38. In all 20 cases, automated analysis identified the same severe genetic variant. Expert curation using additional, representative regions later showed that the finding was erroneous, and none of the individuals had a true medically relevant variant. The researchers described this as an important bioinformatics vulnerability.

The issue relates to the structure of GRCh38, which is based on a single linear reference coordinate system. Although it includes genetic data from multiple individuals, 70% of the data comes from the genome of a male from Buffalo, New York. The researchers said a graph-based pan-genome could provide a richer mapping system that better reflects human genetic diversity. Such a pan-genome graph already exists, but routine clinical use has not yet been realized.

“The whole genomes of 20 healthy Hungarians were compared with the GRCh38 reference genome. In all 20 cases, the automated analysis identified the same severe genetic variant, which was later found to be erroneous following expert curation based on additional, representative regions. In other words, none of them had a true medically relevant variant. The study thus demonstrates an important bioinformatics vulnerability,” said Dr. Balázs Győrffy, head of the Department of Bioinformatics at Semmelweis University and the other lead author of the paper.

“The key question for the future is to what extent information technology will be able to keep pace with advances in medicine. Current everyday IT systems simply cannot support the daily use of such massive databases,” added Dr. Győrffy.

Related Links
Semmelweis University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Immunofluorescence Analyzer
IFA System
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group

Latest Molecular Diagnostics News

Validated Test Predicts Recurrence Risk and Radiation Benefit in Early-Stage Breast Cancer
13 Oct 2026  |   Molecular Diagnostics

Genomic Screening Expands Detection of Treatable Conditions in Newborns
13 Oct 2026  |   Molecular Diagnostics

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants
13 Oct 2026  |   Molecular Diagnostics